Guillermo Calvo Navarrete

DIVERSA Technologies develops tailored lipid nanoparticle delivery systems, providing proprietary solutions that secure freedom-to-operate (FTO) and strong IP protection. We partner with companies across pharma, biotech, animal health, nutraceuticals, and cosmetics to enable the efficient and precise delivery of a wide range of payloads, including mRNA, monoclonal antibodies, proteins, peptides, small molecules, and natural extracts. Our platforms ensure exceptional performance in therapeutic, veterinary, nutritional, and cosmetic applications. Key advantages of DIVERSA’s technology include: Scalability: Seamless transition from lab-scale to industrial manufacturing, maintaining quality and cost-effectiveness., Precision targeting: Optimized delivery to specific tissues or cells, enhancing efficacy and minimizing off-target effects., Improved bioavailability: Maximizes uptake and therapeutic action of actives., Stabilization: Protects and preserves the activity of sensitive molecules in challenging environments., Versatile payload compatibility: Supports nucleic acids (mRNA, siRNA, DNA), biologics (mAbs, proteins), small molecules, and plant extracts. By leveraging our patented platforms and extensive formulation expertise, DIVERSA minimizes regulatory risks and accelerates the development of next-generation solutions. This enables our partners to advance innovative, predictive, and preventive strategies for human and animal health, nutrition, and personal care.